TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Univar to Buy Nexeo for $2 Billion
STOCKS

Brainstorm: new ALS stem cell results support start of pivotal clinical trial

  • By Adam Feuerstein
  • Jul 18, 2016 8:01 AM EDT
PRESS RELEASES

BrainStorm Issues 2020 Letter To Shareholders

  • By PR Newswire
  • Dec 28, 2020 7:00 AM EST
PRESS RELEASES

BrainStorm Announces Completion Of All Dosing In NurOwn® Phase 2 MS Study

  • By PR Newswire
  • Dec 18, 2020 7:00 AM EST
PRESS RELEASES

BrainStorm Announces NurOwn® Expanded Access Program

  • By PR Newswire
  • Dec 14, 2020 7:00 AM EST
PRESS RELEASES

BrainStorm To Present NurOwn® Phase 3 Clinical Trial Results At 31st International Symposium On ALS/MND

  • By PR Newswire
  • Nov 23, 2020 7:00 AM EST
PRESS RELEASES

Rapid Reshore & Development And BrainStorm Cell Therapeutics Announce Agreement To Advance Construction Of BrainStorm's U.S. Manufacturing Facility

  • By PR Newswire
  • Oct 26, 2020 6:00 AM EDT
PRESS RELEASES

BrainStorm To Present At The 2020 Cell & Gene Meeting On The Mesa

  • By PR Newswire
  • Oct 12, 2020 6:00 AM EDT
PRESS RELEASES

BrainStorm Announces Scientific Presentation At The Annual NEALS Meeting

  • By PR Newswire
  • Sep 30, 2020 5:00 AM EDT
PRESS RELEASES

BrainStorm Appoints William K. White As Senior Vice President, Head Of Market Access & Pricing

  • By PR Newswire
  • Sep 29, 2020 6:00 AM EDT
PRESS RELEASES

BrainStorm Appoints Pharmaceutical Veteran Anthony Waclawski As Executive Vice President, Global Head Of Regulatory Affairs

  • By GlobeNewswire
  • Sep 2, 2020 8:30 AM EDT
PRESS RELEASES

BrainStorm To Present Data Linking MRI Measures To Functional Improvement In Progressive Multiple Sclerosis (MS)

  • By PR Newswire
  • Aug 25, 2020 7:39 AM EDT
PRESS RELEASES

BrainStorm Announces Publication Of New Preclinical Data Supporting Proposed NurOwn® Mechanism In ALS, Progressive MS And Alzheimer's Disease

  • By PR Newswire
  • Aug 19, 2020 8:13 AM EDT
PRESS RELEASES

BrainStorm To Present At The 40th Annual Canaccord Genuity Growth Conference

  • By PR Newswire
  • Aug 10, 2020 7:30 AM EDT
PRESS RELEASES

BrainStorm To Showcase Alzheimer's Disease Clinical Program In KOL Webinar

  • By PR Newswire
  • Jul 1, 2020 8:50 AM EDT
PRESS RELEASES

BrainStorm Expands Clinical Pipeline To Evaluate NurOwn® For The Treatment Of Alzheimer's Disease

  • By PR Newswire
  • Jun 24, 2020 7:00 AM EDT
PRESS RELEASES

BrainStorm Cell Therapeutics To Join The Russell 2000® Index And Russell 3000® Index

  • By PR Newswire
  • Jun 23, 2020 5:45 AM EDT
PRESS RELEASES

BrainStorm Granted SME Status By The European Medicines Agency

  • By GlobeNewswire
  • Jun 15, 2020 9:00 AM EDT
PRESS RELEASES

BrainStorm To Present At The Raymond James Human Health Innovations Conference

  • By PR Newswire
  • Jun 11, 2020 7:28 AM EDT
PRESS RELEASES

The ALS Association, I AM ALS Award BrainStorm Cell Therapeutics $500,000 For ALS Biomarker Study

  • By PR Newswire
  • Jun 9, 2020 6:00 AM EDT
PRESS RELEASES

BrainStorm Announces That Pivotal Phase 3 Trial Remains On Track For Topline Data In Q4-2020

  • By PR Newswire
  • Jun 2, 2020 6:00 AM EDT
PRESS RELEASES

BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. As Executive Vice President, Head Of Global Clinical Research

  • By PR Newswire
  • May 27, 2020 7:25 AM EDT
PRESS RELEASES

BrainStorm Leases A New Cleanroom Facility At The Tel Aviv Sourasky Medical Center To Manufacture NurOwn® For The European Union

  • By GlobeNewswire
  • May 7, 2020 1:00 AM EDT
PRESS RELEASES

BrainStorm Presents New Data Highlighting NurOwn® Immunomodulation In Neurology

  • By GlobeNewswire
  • May 4, 2020 3:30 AM EDT
PRESS RELEASES

BrainStorm Awarded $1.5 Million Non-Dilutive Grant For 2020 By The Israel Innovation Authority

  • By GlobeNewswire
  • Apr 3, 2020 6:59 AM EDT
PRESS RELEASES

David Setboun Joins BrainStorm As Executive Vice President And Chief Operating Officer

  • By GlobeNewswire
  • Apr 1, 2020 9:00 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.